Follow us on LinkedIn


A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care

I-SCREEN Revolutionises AMD Care with AI Technology

In a bid to transform the landscape of age-related macular degeneration (AMD) management, I-SCREEN has launched its EIC Pathfinder funded project. With a vision for a future where AMD no longer equates to vision loss, I-SCREEN is leveraging cutting-edge AI technology to achieve this goal.

The project's mission is clear: to develop efficient and cost-effective AI-based infrastructure for early AMD detection and monitoring of disease progression. By creating unique AI-powered diagnostic tools and a cloud-based platform, I-SCREEN aims to empower local eye care professionals, revolutionising AMD care through a novel concept of AI-driven shared care.

This initiative addresses a pressing healthcare challenge, with AMD affecting millions worldwide. I-SCREEN's innovative approach promises accessible and timely treatment through precision image analysis and real-world screening integration.

Stay tuned for more updates on our journey! Follow us on LinkedIn for the latest news and developments.